Cardinal Health Inc
XBER:CLH

Watchlist Manager
Cardinal Health Inc Logo
Cardinal Health Inc
XBER:CLH
Watchlist
Price: 176.25 EUR Market Closed
Market Cap: €27.7B

P/S

0.2
Current
52%
More Expensive
vs 3-y average of 0.1

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.2
=
Market Cap
€53.1B
/
Revenue
$244.7B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.2
=
Market Cap
€53.1B
/
Revenue
$244.7B

Valuation Scenarios

Cardinal Health Inc is trading above its 3-year average

If P/S returns to its 3-Year Average (0.1), the stock would be worth €115.88 (34% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-44%
Maximum Upside
+1 209%
Average Upside
492%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 0.2 €176.25
0%
3-Year Average 0.1 €115.88
-34%
5-Year Average 0.1 €98.74
-44%
Industry Average 1.7 €1 652.9
+838%
Country Average 2.4 €2 307.37
+1 209%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
€53.1B
/
Jan 2026
$244.7B
=
0.2
Current
€53.1B
/
Jun 2026
$261.2B
=
0.2
Forward
€53.1B
/
Jun 2027
$284.9B
=
0.2
Forward
€53.1B
/
Jun 2028
$307.1B
=
0.2
Forward
€53.1B
/
Jun 2029
$334.9B
=
0.2
Forward
€53.1B
/
Jun 2030
$362B
=
0.1
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

Lower than 96% of companies in the United States of America
Percentile
4rd
Based on 11 520 companies
4rd percentile
0.2
Low
0 — 1.2
Typical Range
1.2 — 4.1
High
4.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.2
Median 2.4
70th Percentile 4.1
Max 4 613 274.2

Cardinal Health Inc
Glance View

Cardinal Health Inc., a formidable player in the healthcare sector, operates with the intricacy and precision of a well-orchestrated symphony. At its core, the company thrives on the distribution of pharmaceuticals and medical products, deftly weaving through the complexities of the healthcare supply chain. Cardinal Health serves as a lifeline connecting manufacturers on one end to healthcare providers and pharmacies on the other, ensuring that vital medications and supplies reach those in need efficiently. With a robust logistics network and sophisticated information systems, the company navigates a sprawling array of over 46,000 products, delivering them with diligence to hospitals, clinics, and retail pharmacies across the globe. In its pursuit of business ingenuity, Cardinal Health has expanded its horizons beyond distribution. The company ventures into the vibrant realm of medical and surgical products, offering an array of services that cater to clinical laboratories, ambulatory surgery centers, and more. This diversification not only amplifies its revenue streams but also aligns with its strategic goal of building a comprehensive healthcare ecosystem. Cardinal Health earns its income by capitalizing on a combination of service fees, margins from product sales, and a spectrum of value-added solutions. This intricate blend allows the company to maintain a competitive edge in an era where healthcare demands are ever-evolving and cost-efficiency is paramount. This finely tuned business model is what enables Cardinal Health to sustain its economic vitality and continue its transformative impact on healthcare delivery.

CLH Intrinsic Value
274.71 EUR
Undervaluation 36%
Intrinsic Value
Price €176.25
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett